Oncternal Therapeutics Inc

:ONCT  
0.53
-0.17 (-24.11%)
7:24:29 PM EDT: $0.61 +0.08 (+15.84%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Oncternal Therapeutics Inc Stock, :ONCT

12230 El Camino Real, Suite 230, San Diego, California 92130
United States of America
Phone: +1.858.434.1113
Number of Employees: 27
http://www.oncternal.com

Description

Oncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Its product pipeline include Zilovertamab, ONCT-216, ONCT-808 and ONCT-534. The company was founded by David F. Hale and James B. Breitmeyer in September 1997 and is headquartered in San Diego, CA.